美国食品药品监督管理局 (FDA) 已批准对可手术的 IIA 期至 IIIB 期 NSCLC 患者进行新辅助 nivolumab 联合化疗，随后进行辅助 nivolumab 治疗，这一结果得到了 2023 年 ESMO 大会上公布的 3 期 ...

为解决 Gustilo IIIA 和 IIIB 型胫骨骨折保肢与截肢决策难题，乌干达研究人员开展 GHOISS 评分预测准确性研究。结果显示 GHOISS 评分 13 时预测效果最佳。推荐阅读，助您了解该评分在骨折治疗决策中的重要价值。 在医疗领域，骨折问题一直是个备受关注的话题 ...

RELAX is a phase IIIb, multicenter, randomized, double-blind, placebo-controlled clinical trial designed to evaluate the long-lasting efficacy and satisfaction of RelabotulinumtoxinA in 132 adults ...

2022美国临床肿瘤学会ASCO年会上，来自中国学者的一篇口头发言：新诊断的IIIB-IV期NSCLC患者，心理痛苦与生活质量和免疫检查点抑制剂疗效的相关性。

First results from the phase IIIb RELAX clinical trial reinforce the high and sustained efficacy of single treatment of RelabotulinumtoxinA (Relfydess TM) for moderate to severe frown lines ...

Health Canada has approved MSD’s anti-programmed cell death protein 1 (PD-1) therapy Keytruda for treating adults with ...

According to award notices published on SAM.gov, the U.S. Army Corps of Engineers awarded the Medical Facilities Support Services IIIb contract to the following companies: The awardees will ...

Thailand's women's ice hockey team earned promotion to Division IIIA of the IIHF World Championships after winning the Division IIIB tournament this week in Kohtla-Järve, Estonia. Thailand was ...

Approval was based on results from the Phase IIIb FLOW trial, which demonstrated a 24% relative risk reduction in kidney disease, kidney failure, and cardiovascular death in patients treated with ...